Features
Published | Updated

General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations

Associated Press

NEW YORK – General Electric Co. to sell its biopharma business to Danaher for $21 billion in cash, plus pension obligations.